10-Q/A 1 qa263009.htm AMENDED QUARTERLY REPORT ON FORM 10Q/A-2 FOR THE QUARTER ENDED JUNE 30, 2009 UNITED STATES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________

  

FORM 10-Q-A2

____________________

    

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934

  

For the quarterly period ended June 30, 2009

  

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE EXCHANGE ACT

  

For the transition period from ____________ to____________

  

Commission File No. 000-49652


ZALDIVA, INC.

(Exact name of Registrant as specified in its charter)


 

 

Florida

65-0773383

(State or Other Jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

  


331 East Commercial Blvd.

Ft. Lauderdale, Florida 33334

 (Address of Principal Executive Offices)


(954)938-4133

 (Registrant’s telephone number, including area code)


N/A

(Former name, former address and former fiscal year,

if changed since last report)


Indicate by check mark whether the registrant has (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):


Large accelerated filer [  ]  Accelerated filer [  ]   Non-accelerated filer [  ]  Smaller reporting company [X]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [   ] No [X]



1




APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS


Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.


Not applicable.


APPLICABLE ONLY TO CORPORATE ISSUERS


Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latest practicable date:

August 6, 2009 - Common – 9,018,332

August 6, 2009:  Preferred – 500,000


PART I


Item 1.  Financial Statements


The financial statements of the registrant required to be filed with this 10-Q/A Quarterly Report were prepared by management and commence below, together with related notes. In the opinion of management, the financial statements fairly present the financial condition of the registrant.





2




ZALDIVA, INC.


BALANCE SHEETS



ASSETS

 

 

 

 

 

 

 

June 30,

2009 (Unaudited)

 

September 30, 2008

CURRENT ASSETS:

 

 

 

 

 

     Cash and cash equivalents

$

38,443

 

$

16,967

     Inventories

 

78,641

 

 

80,529

 

 

 

 

 

 

          Total Current Assets

 

117,084

 

 

97,496

 

 

 

 

 

 

PROPERTY & EQUIPMENT, Net

 

638,716

 

 

650,693

 

 

 

 

 

 

          TOTAL ASSETS

$

755,800

 

$

748,189

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

     Accounts payable and accrued expenses

$

5,127

 

$

17,093

     Convertible preferred stock; $0.001 par value, 20,000,000 shares

       Authorized, 500,000 shares issued and outstanding, respectively

 


588,235

 

 


588,235

 

 

 

 

 

 

           Total Current Liabilities

 

593,362

 

 

605,328

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

     Common Stock, $0.001 par value, 50,000,000 shares authorized, 9,018,332

       and 8,213,332 shares issued and outstanding, respectively

 


9,018

 

 


8,213

     Additional paid-in capital

 

2,663,952

 

 

1,730,771

     Accumulated deficit

 

(2,480,532)

 

 

(1,596,123)

 

 

 

 

 

 

           Total Stockholders’ Equity

 

162,438

 

 

142,861

 

 

 

 

 

 

           TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

755,800

 

$

748,189













The accompanying condensed notes are an integral part of these interim financial statements.



3




ZALDIVA, INC.

STATEMENTS OF OPERATIONS

(Unaudited)


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

For the Nine Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2009

 

2008

 

2009

 

2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REVENUES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product Sales

$

61,789

 

$

77,887

 

$

219,779

 

$

195,884

 

Internet Services

 

-

 

 

-

 

 

-

 

 

16,119

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

61,789

 

 

77,887

 

 

219,779

 

 

212,003

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COST OF GOODS SOLD

 

37,283

 

 

43,303

 

 

124,865

 

 

107,100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

24,506

 

 

34,584

 

 

94,914

 

 

104,903

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

639,313

 

 

152,093

 

 

940,950

 

 

460,951

 

Advertising expense

 

      3,683

 

 

             7,381

 

 

9,210

 

 

            16,026

 

Website development expenses

 

-

 

 

4,310

 

 

-

 

 

13,921

 

Depreciation expense

 

3,992

 

 

4,987

 

 

11,977

 

 

14,961

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Operating Expenses

 

646,988

 

 

168,771

 

 

962,137

 

 

505,859

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING LOSS

 

(622,482)

 

 

(134,187)

 

 

(867,223)

 

 

(400,956)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE)

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

124

 

 

19

 

 

461

 

 

948

 

Interest expense

 

(5,882)

 

 

(6,763)

 

 

(17,647)

 

 

(17,647)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income

 

 

 

 

 

 

 

 

 

 

 

 

 

  (Expense)

 

(5,758)

 

 

(6,744)

 

 

(17,186)

 

 

(16,699)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

$

(628,240)

 

$

(140,931)

 

$

(884,409)

 

$

(417,655)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BASIC AND DILUTED  

 

 

 

 

 

 

 

 

 

 

 

 

  LOSS PER SHARE

$

(0.07)

 

$

(0.02)

 

$

(0.10)

 

$

(0.05)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE  

 

 

 

 

 

 

 

 

 

 

 

 

  NUMBER OF SHARES

 

 

 

 

 

 

 

 

 

 

 

 

  OUTSTANDING

 

9,018,332

 

 

8,163,332

 

 

8,584,449

 

 

8,163,332

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying condensed notes are an integral part of these interim financial statements.



4




ZALDIVA, INC.


Statements of Stockholders' Equity

(Unaudited)


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

Total

 

Common Stock

 

Paid-In

 

Accumulated

 

Stockholders'

 

Shares

 

Amount

 

Capital

 

Deficit

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, September 30, 2007

8,163,332

 

$

    8,163

 

$

1,247,477

 

$

(1,027,126)

 

$

228,514

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for cash

   50,000

 

 

    50

 

 

 24,950

 

 

           -

 

 

 25,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of warrants granted

-

 

 

-

 

 

458,344

 

 

-

 

 

 458,344

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the year

 

 

 

 

 

 

 

 

 

 

 

 

 

   ended September 30, 2008

          -

 

 

       -

 

 

          -

 

 

(568,997)

 

 

(568,997)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, September 30, 2008

8,213,332

 

 

 8,213

 

 

1,730,771

 

 

(1,596,123)

 

 

142,861

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for warrants exercised

 305,000

 

 

    305

 

 

  75,945

 

 

-

 

 

 76,250

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for services

500,000

 

 

500

 

 

74,500

 

 

-

 

 

75,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of warrants granted

-

 

 

-

 

 

305,565

 

 

-

 

 

305,565

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of options granted

-

 

 

-

 

 

447,171

 

 

-

 

 

447,171

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss for the nine months

 

 

 

 

 

 

 

 

 

 

 

 

 

   ended June 30, 2009

-

 

 

-

 

 

-

 

 

(884,409)

 

 

(884,409)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance,

 

 

 

 

 

 

 

 

 

 

 

 

 

   June 30, 2009

9,018,332

 

$

9,018

 

$

2,633,952

 

$

(2,480,532)

 

$

162,438

 

 

 

 

 

 

 

 

 

 

 

 

 

 












The accompanying condensed notes are an integral part of these interim financial statements.



5




ZALDIVA, INC.


STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

 

 

 



For the Nine Months Ended

June 30,

 

2009

2008

OPERATING ACTIVITIES

 

 

 

 

   Net loss

$

(884,409)

$

(417,655)

   Adjustments to reconcile net loss to net cash

     Used by operating activities:

 

 

 

 

         Depreciation and amortization

 

11,977

 

14,961

        Common stock used for services

 

         75,000        

 

-

         Fair value of warrants

 

305,565

 

343,758

         Fair value of options

 

447,171

 

-

        Changes in operating assets and liabilities:

 

 

 

 

            (Increase) decrease in inventory

 

1,888

 

4,357

            (Increase) decrease in prepaid expenses

 

-

 

4,263

            Increase (decrease) in current liabilities

 

(11,966)

 

(2,302)

            Increase (decrease) in unearned revenue

 

-

 

(194)

                Net Cash Used by Operating Activities

 

(54,774)

 

(52,812)

 

 

 

 

 

INVESTING ACTIVITIES

 

-

 

-

 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

     Common stock issued for cash

 

76,250

 

-

                Net Cash Provided by Financing Activities

 

76,250

 

-

 

 

 

 

 

     NET DECREASE IN CASH

 

21,476

 

(52,812)

 

 

 

 

 

     CASH AT BEGINNING OF PERIOD

 

16,967

 

77,769

 

 

 

 

 

     CASH AT END OF PERIOD

$

38,443

$

24,957

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

 

 

 

 

 

 

 

 

 

     CASH PAID FOR:

 

 

 

 

      Interest

$

12,173

$

10,001

      Income taxes

$

-

$

-

 

 

 

 

 







The accompanying condensed notes are an integral part of these interim financial statements.



6




ZALDIVA, INC.

Notes to the Condensed Financial Statements

June 30, 2009 and September 30, 2008


NOTE 1 - CONDENSED FINANCIAL STATEMENTS


The accompanying financial statements have been prepared by the Company without audit.  In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at June 30, 2009, and for all periods presented herein, have been made.


Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s September 30, 2008 audited financial statements.  The results of operations for the periods ended June 30, 2009 and 2008 are not necessarily indicative of the operating results for the full years.


NOTE 2 - GOING CONCERN


The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.


In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management’s plan is to obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.


The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.


NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES


Use of Estimates


The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.





7




ZALDIVA, INC.

Notes to the Condensed Financial Statements

June 30, 2009 and September 30, 2008


NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)


Recent Accounting Pronouncements


In May 2009, the FASB issued FAS 165, “Subsequent Events”.  This pronouncement establishes standards for accounting for and disclosing subsequent events (events which occur after the balance sheet date but before financial statements are issued or are available to be issued). FAS 165 requires and entity to disclose the date subsequent events were evaluated and whether that evaluation took place on the date financial statements were issued or were available to be issued. It is effective for interim and annual periods ending after June 15, 2009. The adoption of  FAS 165 did not have a material impact on the Company’s financial condition or results of operation. The Company has evaluated subsequent events through August 14, 2009, the date of issuance of the Company’s financial position and results of operations.


In June 2009, the FASB issued FAS 166, “Accounting for Transfers of Financial Assets” an amendment of FAS 140. FAS 140 is intended to improve the relevance, representational faithfulness, and comparability of the information that a reporting entity provides in its financial statements about a transfer of financial assets: the effects of a transfer on its financial position, financial performance , and cash flows: and a transferor’s continuing involvement, if any, in transferred financial assets. This statement must be applied as of the beginning of each reporting entity’s  first annual reporting period that begins after November 15,  2009. The Company does not expect the adoption of  FAS 166 to have an impact on the Company’s results of operations, financial condition or cash flows.


In June 2009, the FASB issued FAS 167, “Amendments to FASB Interpretation No. 46(R) ”. FAS 167 is intended to (1) address the effects on certain provisions of FASB Interpretation No. 46 (revised December 2003),  Consolidation of Variable Interest Entities, as a result of the elimination of the qualifying special-purpose entity concept in FAS 166, and (2) constituent concerns about the application of certain key provisions of Interpretation 46(R), including those in which the accounting and disclosures under the Interpretation do not always provided timely and useful information about an enterprise’s involvement in a variable interest entity. This statement must be applied as of the beginning of each reporting entity’s  first annual reporting period that begins after November 15,  2009. The Company does not expect the adoption of  FAS 167 to have an impact on the Company’s results of operations, financial condition or cash flows.


In June 2009, the FASB issued FAS 168, “The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles”. FAS 168 will become the source of authoritative U.S. generally accepted accounting principles (GAAP) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws are also sources of authoritative GAAP for SEC registrants. On the effective date of this Statement, the Codification will supersede all then-existing non-SEC accounting and reporting standards. All other nongrandfathered non-SEC accounting literature not included in the Codification will become nonauthoritative. This statement is effective for financial statements issued for interim and annual periods ending after September 15, 2009.The Company does not expect the adoption of  FAS 168 to have an impact on the Company’s results of operations, financial condition or cash flows.










8




ZALDIVA, INC.

Notes to the Condensed Financial Statements

June 30, 2009 and September 30, 2008


NOTE 4 – SIGNIFICANT EVENTS


On or about June 1, 2009, the Company issued a total of 500,000 “unregistered” and “restricted” shares of its common stock to three entities in consideration of services valued at a total of $75,000.


NOTE 5 – RESTATED FINANCIAL STATEMENTS


On or about December 21, 2009 the Board of Directiors of the Company concluded that the Company’s financial statements for the three months and the nine months ended June 30, 2009, should no longer be relied upon because of an error in such financial statements.  These financial statements did not disclose the granting to seven recipients on April 21, 2009, of options to purchase an aggregate of up to 1,810,000 shares of the Company’s common stock at a price of $0.25 per share, exercisable for eight years.


Due to an administrative oversight, the grant of the options was not reflected in the Company’s unaudited financial statements for the three month and nine month periods ended June 30, 2009.  The exclusion of these options resulted in an understatement of General and administrative expenses of $447,171 and an understatement of Additional Paid-in Capital of $447,171.   


































9




Item 2.  Management’s Discussions and Analysis of Financial Condition and Results of Operations.


Forward-looking Statements


Statements made in this Quarterly Report which are not purely historical are forward-looking statements with respect to the goals, plan objectives, intentions, expectations, financial condition, results of operations, future performance and our business, including, without limitation, (i) our ability to raise capital, and (ii) statements preceded by, followed by or that include the words “may,” “would,” “could,” “should,” “expects,” “projects,” “anticipates,” “believes,” “estimates,” “plans,” “intends,” “targets” or similar expressions.


Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond our control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following, general economic or industry conditions, nationally and/or in the communities in which we may conduct business, changes in the interest rate environment, legislation or regulatory requirements, conditions of the securities markets, our ability to raise capital, changes in accounting principles, policies or guidelines, financial or political instability, acts of war or terrorism, other economic, competitive, governmental, regulatory and technical factors affecting our current or potential business and related matters.


Accordingly, results actually achieved may differ materially from expected results in these statements.  Forward-looking statements speak only as of the date they are made.  We do not undertake, and specifically disclaim, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.


Results of Operation


For The Three Months Ended June 30, 2009 Compared to The Three Months Ended June 30, 2008.


During the quarterly period ended June 30, 2009, we received total revenues of $61,789, a decrease of $16,098, or approximately 20%, over our total revenues of $77,887 in the quarterly period ended June 30, 2008. We have focused our marketing on collectibles and comic book sales.  The decreased sales were the result of a generally worse retail environment in the second calendar quarter of 2009 as compared to the year-ago period.  Costs of goods sold during these periods were $37,283 and $43,303, respectively. Cost of goods sold was approximately 60% and 56% of sales for 2009 and 2008, respectively.


Operating expenses increased to $646,988 during the quarterly period ended June 30, 2009, from $168,771 in the year-ago period.  This increase was due primarily to a increase of approximately 416% in general and administrative expenses, from $152,093 to $639,313, from the 2008 period to the 2009 period due to the issuance of options valued at $447,171.


For the three months ended June 30, 2009, we had a net loss of $628,240, or $0.07 per share as compared to a net loss of $140,931, or $0.02 per share during the June 30, 2008 period.  Included in operating expenses for the June 30, 2009 quarterly period was $523,564 for the value of compensatory options and warrants granted to our officers and directors, as compared to $114,586 in the quarterly period ended June 30, 2008.  Excluding this non-cash expense, our net loss would have been only $104,676 and $26,345 in 2009 and 2008, respectively.  The amortization of this expense ended in May, 2009.


For The Nine Months Ended June 30, 2009 Compared to The Nine Months Ended June 30, 2008.


During the nine months ended June 30, 2009, we received total revenues of $219,779, an increase of  $7,776, or approximately 4%,  over our total revenues of $212,003 for the nine months ended June 30, 2008. Costs of goods sold during these periods were $124,865 and $107,100, respectively. Cost of goods sold was approximately 57% and 51% of sales for 2009 and 2008, respectively.




10




Operating expenses increased by approximately 90%, to $962,137 during the nine months ended June 30, 2009, from $505,859 in the year-ago period.  This increase is attributable to compensation expense associated with the issuance of options totaling $447,171.


For the nine months ended June 30, 2009, we had a net loss of $884,409, or $0.10 per share, as compared to a net loss of $417,655, or $0.05 per share during the June 30, 2008 period.   Included in operating expenses for 2009 was $305,565 for the value of compensatory warrants granted to our officers and directors and $447,171 for the value of compensatory options issued to our officers and directors; this figure was $343,758 in the 2008 period.  Excluding this non-cash expense, our net loss would have been only $131,673  in 2009 and $73,897 in 2008.  The amortization of this expense ended in May 2009.


Liquidity


The Company had cash on hand of $38,443 at June 30, 2009. We believe that this cash on hand may not be sufficient to meet our expenses through the end of our 2009 fiscal year.  


Our revenues tend to increase significantly in the Thanksgiving to Christmas holiday season.  If we are not able to sustain an operating profit, we expect that we will have to raise money again by selling shares of common stock or through loans. Financing for the Company's activities to date has been primarily provided by issuance of common or preferred stock for cash and for services. During the nine months ended June 30, 2009, we received $76,250 upon the exercise of 305,000 warrants at $0.25 per share.  Our ability to achieve a level of profitable operations and/or additional financing may affect our ability to continue as a going concern.


Item 3.  Quantitative and Qualitative Disclosures About Market Risk.


Not required.


Item 4T.  Controls and Procedures.


Evaluation of disclosure controls and procedures


Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q.  In designing and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.  In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.  The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.


Based on that evaluation, our chief executive officer and chief financial officer concluded that, as of June 30, 2009, our disclosure controls and procedures were not effective.  In connection with the preparation of our financial statements for the fiscal year ended September 30, 2009, we identified a deficiency that existed in the design or operation of our internal control over financial reporting that we consider to be a “material weakness.”  The Public Company Accounting Oversight Board has defined a material weakness as a “significant deficiency or combination of significant deficiencies that results in more than a remote likelihood that a material misstatement on the annual or interim financial statements will not be prevented or detected.”

The material weakness identified relates to our recording, review and control of material information required to be included in our periodic Securities and Exchange Commission reports and our communication of such material information to our attorneys and accountants such that it can be properly disclosed in our periodic reports.  This material weakness resulted in failure to properly report and disclose information and matters affecting the



11




Company’s financial statements for the three month and nine month periods ended June 30, 2009, and related footnotes.  This amended Quarterly Report on Form 10-Q-A2 is filed for the purpose of correcting these failures.


During the first quarter of our 2010 fiscal year, we took the following step to remediate the weakness identified under the subheading “Evaluation of disclosure controls and procedures” above:

 

Communication with corporate counsel and accountants prior to the adoption of any corporate resolution providing for the issuance of shares of our common stock, the granting of options and

other material events that require disclosure in our periodic Securities and Exchange Commission reports, and quarterly conferences with our counsel to ensure that all corporate actions undertaken during the prior quarter have been properly documented.


The Company will continue to monitor, assess and work to improve the effectiveness of its internal control procedures related to internal controls and financial reporting in order to comply with Section 404 of the Sarbanes Oxley Act of 2002.   


Changes in internal control over financial reporting


Our management, with the participation of the chief executive officer and chief financial officer, has concluded there were no significant changes in our internal controls over financial reporting that occurred during the fiscal quarter ended June 30, 2009, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


During the first quarter of our 2010 fiscal year, we took the following step to remediate the weakness identified under the subheading “Evaluation of disclosure controls and procedures” above:

 

Communication with corporate counsel and accountants prior to the adoption of any corporate resolution providing for the issuance of shares of our common stock, the granting of options and

other material events that require disclosure in our periodic Securities and Exchange Commission reports, and quarterly conferences with our counsel to ensure that all corporate actions undertaken during the prior quarter have been properly documented.   We believe that this change will have a commensurate effect on our internal controls over financial reporting.


PART II - OTHER INFORMATION

  

Item 1. Legal Proceedings. 


None; not applicable.

  

Item 1A.  Risk Factors.


Not required.


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

  

On or about June 1, 2009, the Company issued a total of 500,000 “unregistered” and “restricted” shares of its common stock to the three entities identified below, in consideration of services valued at a total of $75,000:


Name

No. of Shares


International Monetary

80,000

Biosystic Systems, Inc.

350,000

Jeffrey A. Olweean

 70,000




12




These shares were issued in reliance on the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended.

  

Item 3. Defaults Upon Senior Securities.

  

None; not applicable.

  

Item 4. Submission of Matters to a Vote of Security Holders.

  

None; not applicable.

  

Item 5. Other Information.

  

None; not applicable.   


Item 6. Exhibits.


Exhibit No.                           Identification of Exhibit


 

 

31.1

  

31.2

  

32

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Nicole Leigh, President and Director.


Certification Pursuant to Section 302 of the Sarbanes-Oxley Act provided by Robert B. Lees, Chief Financial Officer and Director.


Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 provided by Nicole Leigh, President and Robert B. Lees, Chief Financial Officer.




13




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

  

ZALDIVA, INC.


 

 

 

 

 

Date:

January 12, 2010

  

By:

/s/Nicole Leigh

  

  

  

  

Nicole Leigh, President and Director


 

 

 

 

 

Date:

January 12, 2010

  

By:

/s/Robert B. Lees

  

  

  

  

Robert B. Lees, CFO, and Director


 

 

 

 

 

Date:

January 12, 2010

  

By:

/s/John A. Palmer, Jr.

  

  

  

  

John A. Palmer, Jr., Secretary and Director



14